3 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 6 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Chemo Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Levonorgestrel Vaginal System Levonorgestrel - Contraceptive Usage | Phase 3 | Not yet recruiting | Chemo Research | 1600 | 2026-12-01 | 2026-07-29 |
| Efficacy of INM004 in Children With STEC-HUS INM004, Placebo - Hemolytic-Uremic Syndrome | Phase 3 | Recruiting | Inmunova S.A. | 220 | 2024-10-05 | 2026-01-15 |
| A Trial of Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles LVDS - Contraception | Phase 3 | Completed | Chemo Research | 1039 | 2023-08-09 | 2026-04-21 |
| Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females Drospirenone - Contraception, Change in Bone Mineral Density | Phase 3 | Completed | Insud Pharma | 1542 | 2022-08-02 | 2025-10-08 |
| LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet - Change in Bone Mineral Density, Bone Loss | Phase 4 | Active not recruiting | Insud Pharma | 1536 | 2022-03-28 | 2026-04-09 |
| A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles LPRI424 (dienogest/ethinylestradiol) - Contraception | Phase 3 | Completed | Insud Pharma | 1034 | 2019-12-03 | 2023-11-14 |
| Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease Benznidazole - Chagas Disease | Phase 3 | Active not recruiting | Insud Pharma | 178 | 2019-09-19 | 2026-04-21 |
Contraception Behavior (2) · Bone Diseases, Metabolic (1) · Chagas Disease (1) · Hemolytic-Uremic Syndrome (1) · Osteoporosis (1)
drospirenone (2) · Ethinyl Estradiol (1) · Exercise (1) · Levonorgestrel (1) · Tablets (1) · benzonidazole (1) · dienogest (1)
United States (3) · Argentina (2) · Spain (2) · Belgium (1) · Bolivia (1) · Canada (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Poland (1) · Romania (1) · United Kingdom (1)
Enrico Colli, MD (3) · Santiago Sanguineti, Ph.D (1)